Zhanjun Jia

910 total citations
27 papers, 762 citations indexed

About

Zhanjun Jia is a scholar working on Molecular Biology, Nephrology and Biochemistry. According to data from OpenAlex, Zhanjun Jia has authored 27 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Nephrology and 5 papers in Biochemistry. Recurrent topics in Zhanjun Jia's work include Eicosanoids and Hypertension Pharmacology (4 papers), Parathyroid Disorders and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Zhanjun Jia is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (4 papers), Parathyroid Disorders and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Zhanjun Jia collaborates with scholars based in China, United States and Australia. Zhanjun Jia's co-authors include Tianxin Yang, Toshinori Aoyagi, Guangrui Yang, Aihua Zhang, J. David Symons, Jürgen Schnermann, Hui Zhang, Sheldon E. Litwin, Frank J. Gonzalez and Ningning Wang and has published in prestigious journals such as PLoS ONE, Cell Metabolism and Journal of Applied Physiology.

In The Last Decade

Zhanjun Jia

25 papers receiving 757 citations

Peers

Zhanjun Jia
Mohammed Yaqoob United Kingdom
Corry D. Bondi United States
Qingshang Yan United States
J. Dananberg United States
David Mordasini Switzerland
Mohammed Yaqoob United Kingdom
Zhanjun Jia
Citations per year, relative to Zhanjun Jia Zhanjun Jia (= 1×) peers Mohammed Yaqoob

Countries citing papers authored by Zhanjun Jia

Since Specialization
Citations

This map shows the geographic impact of Zhanjun Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanjun Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanjun Jia more than expected).

Fields of papers citing papers by Zhanjun Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanjun Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanjun Jia. The network helps show where Zhanjun Jia may publish in the future.

Co-authorship network of co-authors of Zhanjun Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanjun Jia. A scholar is included among the top collaborators of Zhanjun Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanjun Jia. Zhanjun Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Mengqiu, Yuting Li, Jiaojiao Fan, et al.. (2025). Targeting renal tubular WWP2 to restore mitochondrial OXPHOS integrity retards the AKI-to-CKD transition. Molecular Therapy. 34(3). 1576–1596. 1 indexed citations
2.
Yang, Xinyu, Hanyang Wu, Zhanjun Jia, et al.. (2025). Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity. Molecular Cancer. 24(1). 4–4. 7 indexed citations
3.
Li, Shuzhen, Shuang Kang, Yue Zhang, et al.. (2025). Endothelial MicroRNA-214 Confers Angiotensin II Hypertension by Targeting eNOS in Mice. Kidney & Blood Pressure Research. 50(1). 442–459.
4.
Wang, Qian, Zhenzhen Sun, Le Sun, et al.. (2024). USP13 inhibition exacerbates mitochondrial dysfunction and acute kidney injury by acting on MCL-1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167599–167599.
5.
Luo, Qimei, Mi Liu, Yanhong Tan, et al.. (2022). Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis. Frontiers in Pharmacology. 13. 1004619–1004619. 4 indexed citations
6.
Yu, Jing, Shuqin Wang, Wei Shi, et al.. (2021). Roxadustat prevents Ang II hypertension by targeting angiotensin receptors and eNOS. JCI Insight. 6(18). 36 indexed citations
7.
Zheng, Bixia, Chunli Wang, Qiuxia Chen, et al.. (2020). Functional Characterization of PHEX Gene Variants in Children With X-Linked Hypophosphatemic Rickets Shows No Evidence of Genotype–Phenotype Correlation. Journal of Bone and Mineral Research. 35(9). 1718–1725. 27 indexed citations
8.
Li, Shuzhen, Yue Zhang, Songming Huang, et al.. (2018). Dihydroartemisinin inhibits indoxyl sulfate (IS)-promoted cell cycle progression in mesangial cells by targeting COX-2/mPGES-1/PGE2 cascade.. PubMed. 10(2). 422–431. 5 indexed citations
9.
Zhang, Rui, Zhanjun Jia, Zhengxin Chen, et al.. (2016). Tumor Suppressor Candidate 1 Suppresses Cell Growth and Predicts Better Survival in Glioblastoma. Cellular and Molecular Neurobiology. 37(1). 37–42. 9 indexed citations
10.
Zhu, Ziyang, et al.. (2016). Insights from lncRNAs Profiling of MIN6 Beta Cells Undergoing Inflammation. Mediators of Inflammation. 2016. 1–10. 18 indexed citations
11.
Zhou, Li, et al.. (2015). Systemic PPARγ deletion causes severe disturbance in fluid homeostasis in mice. Physiological Genomics. 47(11). 541–547. 10 indexed citations
12.
Yang, Boyu, Yue Zhang, Chunjie Wang, et al.. (2013). Effects of meteorological elements on admission rates of cerebral infarction patients with hypertensive nephropathy from nine hospitals in Changchun city, Jilin Province. Chinese Medical Journal. 126(10). 1934–1938. 10 indexed citations
13.
Yang, Guangrui, Zhanjun Jia, Toshinori Aoyagi, et al.. (2012). Systemic PPARγ Deletion Impairs Circadian Rhythms of Behavior and Metabolism. PLoS ONE. 7(8). e38117–e38117. 70 indexed citations
14.
Zhang, Aihua, et al.. (2011). Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney International. 80(1). 51–60. 34 indexed citations
15.
Jia, Zhanjun, Toshinori Aoyagi, Donald E. Kohan, & Tianxin Yang. (2010). mPGES-1 deletion impairs aldosterone escape and enhances sodium appetite. American Journal of Physiology-Renal Physiology. 299(1). F155–F166. 30 indexed citations
16.
Tanner, Jason M., Bum‐Joon Kim, Crystal Sloan, et al.. (2010). Fasting-induced reductions in cardiovascular and metabolic variables occur sooner in obese versus lean mice. Experimental Biology and Medicine. 235(12). 1489–1497. 11 indexed citations
17.
Wang, Ningning, Guangrui Yang, Zhanjun Jia, et al.. (2008). Vascular PPARγ Controls Circadian Variation in Blood Pressure and Heart Rate through Bmal1. Cell Metabolism. 8(6). 482–491. 199 indexed citations
18.
Ye, Furong, Eun‐Kee Jeong, Zhanjun Jia, et al.. (2008). A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI. Bioconjugate Chemistry. 19(12). 2300–2303. 73 indexed citations
19.
Nie, Jing, Wenke Hao, Xin Wang, et al.. (2007). Smad7 gene transfer inhibits peritoneal fibrosis. Kidney International. 72(11). 1336–1344. 64 indexed citations
20.
Liu, Haiying, Wenling Ye, Guangju Guan, et al.. (2007). Developmental regulation of calcineurin isoforms in the rodent kidney: association with COX-2. American Journal of Physiology-Renal Physiology. 293(6). F1898–F1904. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026